Diabetes mellitus and aortic stenosis head to head: toward personalized medicine in patients with both pathologies

被引:1
|
作者
Corbacho-Alonso, Nerea [1 ]
Sastre-Oliva, Tamara [1 ]
Lopez-Almodovar, Luis F. [2 ]
Solis, Jorge [3 ,4 ,5 ,6 ]
Padial, Luis R. [7 ]
Tejerina, Teresa [8 ]
Carrascal, Montserrat [9 ]
Mourino-Alvarez, Laura [1 ]
Barderas, Maria G. [1 ,10 ]
机构
[1] Hosp Nacl Paraplej, Inst Invest Sanitaria Castilla La Mancha IDISCAM, Dept Vasc Physiopathol, Toledo, Spain
[2] Hosp Gen Univ Toledo, Cardiac Surg, SESCAM, Toledo, Spain
[3] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[4] Inst Invest Sanitaria Hosp 12 Octubre imas12, Madrid, Spain
[5] AtriaClinic, Madrid, Spain
[6] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Madrid, Spain
[7] Hosp Gen Univ Toledo, Dept Cardiol, SESCAM, Toledo, Spain
[8] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[9] Inst Invest Biomed Barcelona, Biol & Environm Prote, CSIC, IDIBAPS, Barcelona, Spain
[10] Hosp Nacl Paraplej SESCAM, Lab Fisiopatol Vasc, Edificio Invest 1 Planta,Despacho 3, Toledo 45071, Spain
关键词
Biomarkers; Calcific aortic stenosis; Diabetes mellitus; Personalized medicine; Proteomics; VALVE; FIBRINOLYSIS; INHIBITOR; SCLEROSIS; DISEASE; CELLS; RISK; PEDF;
D O I
10.1016/j.trsl.2023.04.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Diabetes mellitus (DM) and calcific aortic stenosis (CAS) are common morbidities in the elderly, which are both chronic, progressive and often concomitant diseases. Several studies revealed that DM increases the risk of developing severe CAS, yet clear information about the relationship between both these diseases and the influence of DM on the progression of CAS is currently lacking. To evaluate the effect of DM on aortic valves and on the process of calcification, and to achieve better patient management in daily clinical practice, we analysed calcified and noncalcified valve tissue from patients with severe CAS, with or without DM. A proteomic strategy using isobaric tags was adopted and the plasma concentrations of nine proteins were studied using 3 orthogonal methods and in a separate cell model. The differentially expressed proteins identified are implicated in biological processes like endopeptidase activity, lipid metabolism, coagulation, and fibrinolysis. The results obtained provide evidence that DM provokes changes in the proteome of aortic valves, affecting valve calcification. This finding may help enhance our understanding of the pathogenesis of CAS and how DM affects the evolution of this condition, an important step in identifying targets to personalize the treatment of these patients.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 50 条
  • [1] Introduction to Personalized Medicine in Diabetes Mellitus
    Glauber, Harry S.
    Rishe, Naphtali
    Karnieli, Eddy
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2014, 5 (01):
  • [2] Diabetes Mellitus and Its Implications in Aortic Stenosis Patients
    Mourino-Alvarez, Laura
    Corbacho-Alonso, Nerea
    Sastre-Oliva, Tamara
    Corros-Vicente, Cecilia
    Solis, Jorge
    Tejerina, Teresa
    Padial, Luis R.
    Barderas, Maria G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [3] Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis
    Coisne, Augustin
    Montaigne, David
    Ninni, Sandro
    Lamblin, Nicolas
    Lemesle, Gilles
    Delsart, Pascal
    Filiot, Alexandre
    Andrey, Paul
    Balaye, Pierre
    Butruille, Laura
    Decoin, Raphael
    Woitrain, Eloise
    Granada, Juan F.
    Staels, Bart
    Bauters, Christophe
    HEART, 2022, 108 (22) : 1815 - 1821
  • [4] Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Surgery
    Raikundalia, Milap D.
    Fang, Christina H.
    Spinazzi, Eleonora F.
    Vazquez, Alejandro
    Park, Richard Chan
    Baredes, Soly
    Eloy, Jean Anderson
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 154 (02) : 294 - 299
  • [5] Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
    Avery, Peter
    Mousa, Shaymaa S.
    Mousa, Shaker A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2009, 2 : 79 - 91
  • [6] Translational genomics and head and neck cancer: toward precision medicine
    Razzouk, S.
    CLINICAL GENETICS, 2014, 86 (05) : 412 - 421
  • [7] Diabetes mellitus, metformin and head and neck cancer
    de Oliveira Figueiredo, Rejane Augusta
    Weiderpass, Elisabete
    Tajara, Eloiza Helena
    Strom, Peter
    Carvalho, Andre Lopes
    de Carvalho, Marcos Brasilino
    Kanda, Jossi Ledo
    Moyses, Raquel Ajub
    Wunsch-Filho, Victor
    ORAL ONCOLOGY, 2016, 61 : 47 - 54
  • [8] Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
    Kuo, Hsuan-Chih
    Chang, Pei-Hung
    Wang, Cheng-Hsu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Pharmacogenomics in Diabetes Mellitus: Pathway to Personalized Medicine
    Sree, Karuna P.
    Yadav, Haritha K. C.
    Rao, Venkat Y.
    HELIX, 2013, 1 : 215 - 220
  • [10] Diabetes mellitus is associated with an increased incidence of aortic valve stenosis
    Roderburg, Christoph
    Loosen, Sven H.
    Luedde, Tom
    Kostev, Karel
    Luedde, Mark
    DIABETES & VASCULAR DISEASE RESEARCH, 2021, 18 (05):